Investment Philosophy

NeuMedix Health Group through its affiliated Investment companies are specialist financiers of innovative technology developed for the medical, agricultural and food science industries. 

The team of scientists, lawyers, financiers and business specialists involved identify innovation, invest, enhance and protect it to ensure success for the technology and benefits for the community. 

Once the decision is made to support an inventor and invest, a company is formed to manage the specifics of the innovation. This can include the ongoing medical research necessary to commercialise the technology, and provide a wide range of professional services.

Commercialisation is a complex journey and The NeuMedix Health Group understands the process and pitfalls. 

If necessity is the mother of invention then distraction is the devil of delivery. Concentration should never be diverted from the core concept and just as an artist will work tirelessly to complete a masterpiece so too must scientists focus on their technology. Often when success seems close the community’s enthusiasm for a favourable outcome can hamper completion. Similarly a potential medical breakthrough will often encourage unsolicited interest from parties whose intrusion is more aligned to shareholder profit than human benefit. 

The ethical delivery of technology, enrichment of life and recognition for achievement are core commercial pillars for all companies in the NeuMedix Health Group. A lifetime of research and development culminating with the release of a medical marvel deserves not just the accolades but also compensation commensurate with outcome. With our support, expertise and funding the journey will be well planned, clearly documented and deliver an excellent result.